Journal of Urologic Oncology

Renal Cell Carcinoma

Comparison of Outcomes Between Radical Nephrectomy and Partial Nephrectomy in Clinical T2 Renal Cell Carcinoma: A Retrospective Korean Renal Cell Carcinoma Cohort Study: Younsoo Chung, Seok-Soo Byun, Sung Kyu Hong, Sangchul Lee, Chang Wook Jeong, Seok Ho Kang, Sung-Hoo Hong, Ji Youl Lee, Yong-June Kim, Jinsoo Chung, Eu Chang Hwang, Tae Gyun Kwon, Jung Kwon Kim; Journal of Urologic Oncology. 2024;22(2):136-143. Published online July 31, 2024; DOI: https://doi.org/10.22465/juo.244800360018
Cited By 1; Full text PubReader ePub PDF Supplementary Material

Pathologic Diagnosis of Renal Cell Carcinoma in the Era of the 2022 World Health Organization Classification: Key Points for Clinicians: Bokyung Ahn, Jinahn Jeong, Yong Il Lee, Ja-Min Park, Sun Young Yoon, Cheryn Song, Yong Mee Cho; Journal of Urologic Oncology. 2024;22(2):115-127. Published online July 31, 2024; DOI: https://doi.org/10.22465/juo.244800440022
Cited By 1; Full text PubReader ePub PDF

Robot-Assisted Radical Nephrectomy With Inferior Vena Cava Thrombectomy: A Narrative Review With Step-by-Step Procedures: Seokhwan Bang, Sung-Hoo Hong; Journal of Urologic Oncology. 2024;22(2):105-114. Published online July 31, 2024; DOI: https://doi.org/10.22465/juo.244800420021
Cited By 1; Full text PubReader ePub PDF

A Narrative Review on Systemic Therapy for Renal Cell Carcinoma in the Perioperative Setting: Isamu Tachibana, Qian Qin, Jacob Taylor, Wadih Issa, Jeffrey Cadeddu, Vitaly Margulis, Tian Zhang; Journal of Urologic Oncology. 2024;22(2):100-104. Published online July 31, 2024; DOI: https://doi.org/10.22465/juo.244800500025
Cited By 1; Full text PubReader ePub PDF

Kidney Cancer

Clinical Characteristics and Outcomes of TFE3-Rearranged/TFEB-Altered Renal Cell Carcinoma with Systemic Therapies, Including Tyrosine Kinase Inhibitors or Immune Checkpoint Inhibitors: An Observational Study: Joohyun Hong, Ghee Young Kwon, Minyong Kang, Seong Il Seo, Se Hoon Park; Journal of Urologic Oncology. 2024;22(1):59-67. Published online March 31, 2024; DOI: https://doi.org/10.22465/juo.234600660033
Cited By 1; Full text PubReader ePub PDF

Prognostic Factors and Cancer-Specific Survival of Surgically Managed Renal Cell Carcinoma With Venous Thrombus: A 30-Year Experience at a Tertiary Referral Center: Hyun Young Lee, Yunjoong Kim, Bumjin Lim, Dalsan You, Cheryn Song, In Gab Jeong, Bumsik Hong, Jun Hyuk Hong, Hanjong Ahn, Jungyo Suh; Journal of Urologic Oncology. 2024;22(1):52-58. Published online March 31, 2024; DOI: https://doi.org/10.22465/juo.234600600030
Cited By 1; Full text PubReader ePub PDF

Global Renal Cell Carcinoma Research Trends Over 30 Years: A PRISMA-Compliant Bibliometric Analysis: Jung Hoon Kim, Ji Woong Hwang; Journal of Urologic Oncology. 2024;22(1):42-51. Published online March 31, 2024; DOI: https://doi.org/10.22465/juo.244600120006
Cited By 1; Full text PubReader ePub PDF

Targeted Therapy Following Metastasectomy for Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-analysis: Hui Mo Gu, Seung Il Jung, Dongdeuk Kwon, Myung Ha Kim, Jae Hung Jung, Mi Ah Han, Seung Hwan Lee, In Gab Jeong, Sun Il Kim, Eu Chang Hwang; Journal of Urologic Oncology. 2024;22(1):34-41. Published online March 31, 2024; DOI: https://doi.org/10.22465/juo.244600140007
Cited By 1; Full text PubReader ePub PDF Supplementary Material

Perioperative Considerations and Treatment for Advanced Renal Cell Carcinoma

Role of Radiotherapy in Metastatic Renal Cell Carcinomas: An Evolutionary Journey in a Misunderstood Histological Type: Chan Woo Wee, Jaeho Cho; Journal of Urologic Oncology. 2023;21(3):217-227. Published online November 30, 2023; DOI: https://doi.org/10.22465/juo.234600560028
Cited By 1; Full text PubReader ePub PDF

The Future of Adjuvant Therapy in Renal Cell Carcinoma: Recent Insights and Prospects: Hyerim Ha, Joo Han Lim; Journal of Urologic Oncology. 2023;21(3):208-216. Published online November 30, 2023; DOI: https://doi.org/10.22465/juo.234600540027
Cited By 1; Full text PubReader ePub PDF

Preoperative Renal Artery Embolization Before Radical Nephrectomy for Nonmetastatic Renal Cell Carcinoma: A Propensity Score Matched Analysis: Jin Noh, Sang Hun Song, Gyoohwan Jung, Sangchul Lee, Sung Kyu Hong, Seok Soo Byun, Jung Kwon Kim; Journal of Urologic Oncology. 2023;21(3):200-207. Published online November 30, 2023; DOI: https://doi.org/10.22465/juo.234600480024
Cited By 1; Full text PubReader ePub PDF

Influence of Body Composition on the Perioperative and Survival Outcomes of Renal Cell Carcinoma: Edouard H. Nicaise, Benjamin N. Schmeusser, Yash B. Shah, Mehmet A. Bilen, Kenneth Ogan, Viraj A. Master; Journal of Urologic Oncology. 2023;21(3):183-199. Published online November 30, 2023; DOI: https://doi.org/10.22465/juo.234600500025
Cited By 2; Full text PubReader ePub PDF

Trimodality Therapy and Immuno-Oncology for Bladder Cancer

The Predictive Value of the Preoperative Systemic Inflammatory Response Indices in Non–Organ-Confined Disease in Upper Urinary Tract Urothelial Carcinoma: Sung Kyung Choi, Chan Hoon Gwak, Jungyo Suh, Bumjin Lim, Cheryn Song, Dalsan You, In Gab Jeong, Jun Hyuk Hong, Bumsik Hong, Choung-Soo Kim, Hanjong Ahn; Journal of Urologic Oncology. 2023;21(2):174-180. Published online July 31, 2023; DOI: https://doi.org/10.22465/juo.224400580029
Cited By 1; Full text PubReader ePub PDF

Radical Cystectomy Versus Bladder-Preserving Therapy in Muscle-Invasive Bladder Cancer Patients After Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Multicenter Retrospective Analysis: Youngheun Jo, Jun Seok Kim, Yoo Sub Shin, Jongchan Kim, Won Sik Jang, Jee Soo Park, Won Sik Ham; Journal of Urologic Oncology. 2023;21(2):165-173. Published online July 31, 2023; DOI: https://doi.org/10.22465/juo.234600280014
Cited By 1; Full text PubReader ePub PDF Supplementary Material

The Evolving Role of Checkpoint Inhibitors in the Treatment of Urothelial Carcinoma: A Literature Review of Practice-Changing Trials: Sang Hun Song, Jong Jin Oh; Journal of Urologic Oncology. 2023;21(2):154-164. Published online July 31, 2023; DOI: https://doi.org/10.22465/juo.234600300015
Cited By 3; Full text PubReader ePub PDF

5,262	New Drugs for Bacillus Calmette Guérin-Unresponsive Nonmuscle Invasive Bladder Cancer
4,829	The Important Role of Poly ADP-Ribose Polymerase Inhibitor in Prostate Cancer
4,201	The Present and Future of Intravesical Therapy in Bladder Cancer
3,980	An Update of Prostate-Specific Membrane Antigen Theranostics in Prostate Cancer
3,928	Complex Epidemiology of Prostate Cancer in Asian Countries

Cited By 6	Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades
Cited By 4	An Update of Prostate-Specific Membrane Antigen Theranostics in Prostate Cancer
Cited By 3	The Evolving Role of Checkpoint Inhibitors in the Treatment of Urothelial Carcinoma: A Literature Review of Practice-Changing Trials
Cited By 2	Complex Epidemiology of Prostate Cancer in Asian Countries
Cited By 2	Prostate Imaging and Reporting and Data System Version 2.1: Limitations for Clinical Use

Search